Objective: Understanding the role of
apoptosis in abnormal neurodevelopment and neurodegenerative processes is
crucial. In this study, it is aimed to determine how apoptosis biomarkers are
affected in patients with schizophrenia and severity of the disease and also whether
apoptosis biomarkers can be used as blood-based biomarkers in diagnosis of the
disease.
Method: This is a cross-sectional prospective study performed at a tertiary
university hospital and city hospital in Turkey. Volunteers
(n=60) diagnosed with schizophrenia were divided into three groups (Mild,
Moderate and Severe) according to the Clinical Global Impressions Scale
developed by Guy. The control group was constituted from volunteers who were
similar to the patient group (n=40) in terms of age and gender. Serum levels of
Caspase-8(C-8), Granzyme B (GrB) and Cytcochrome C (CYCS) were measured by
ELISA method from blood samples collected from patient and control groups.
Results: It was observed that Caspase 8 and GrB levels
were lower in all three groups compared with the control group, and the highest
decrease was in the 3rd group (P<0,.5). CYCS level on the other hand
increased, and the highest increase was observed in 3rd Group (P<0.05).
Conclusions: It is hypothesised that increase in serum CYCS level of patients with
schizophrenia may be a blood based biomarker in which apoptosis occurs.
Primary Language | English |
---|---|
Subjects | Health Care Administration |
Journal Section | Basic Science Research Articles |
Authors | |
Publication Date | June 30, 2019 |
Acceptance Date | June 24, 2019 |
Published in Issue | Year 2019 |